Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,400
Closed -$23.4K 295
2024
Q2
$23.4K Sell
1,400
-150
-10% -$2.31K ﹤0.01% 280
2024
Q1
$23.6K Sell
1,550
-350
-18% -$4.57K ﹤0.01% 315
2023
Q4
$19.4K Sell
1,900
-200
-10% -$2.17K ﹤0.01% 306
2023
Q3
$24.9K Buy
2,100
+100
+5% +$1.22K ﹤0.01% 279
2023
Q2
$23.4K Hold
2,000
﹤0.01% 283
2023
Q1
$22.8K Hold
2,000
﹤0.01% 275
2022
Q4
$26.2K Buy
2,000
+350
+21% +$7.12K ﹤0.01% 275
2022
Q3
$38K Hold
1,650
﹤0.01% 260
2022
Q2
$37K Hold
1,650
﹤0.01% 272
2022
Q1
$43K Buy
1,650
+450
+38% +$14K ﹤0.01% 273
2021
Q4
$38K Buy
+1,200
New +$45.5K ﹤0.01% 280

Other funds holding CANG

Aspiriant LLC's CANG Position: Q3 2024 in Review

Aspiriant LLC sold out of Cango Inc (CANG) in Q3 2024, closing a stake of 1,400 shares — an estimated $23.4K sold.

Aspiriant LLC first reported a position in CANG in Q4 2021 and held it in 11 quarters. The position peaked at $43K in Q1 2022. 24 funds tracked by Wall St. Rank hold CANG as of Q3 2024.

  • Aspiriant LLC reported no remaining Cango Inc position as of Q3 2024 after selling out during the quarter.
  • Aspiriant LLC sold 1,400 Cango Inc shares in Q3 2024, an estimated $23.4K.
  • Aspiriant LLC first reported a position in Cango Inc in Q4 2021 and held it in 11 quarters.
  • Aspiriant LLC's Cango Inc position peaked at $43K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Cango Inc as of Q3 2024.

Based on Aspiriant LLC's 13F filing for Q3 2024, filed 17 Oct 2024.